Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Recruiting × tepotinib × Clear all

Phase

Phase 2 3 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Completed 2 Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 106 Specimen Handling 99 pembrolizumab 97 Magnetic Resonance Spectroscopy 87 fludarabine 84 Biopsy 74 Injections 44 venetoclax 38 Bevacizumab 38 Carboplatin 36 Paclitaxel 34 Nivolumab 34 Cisplatin 34 Radiotherapy 33 Fluorouracil 33 Cetuximab 32 fludarabine phosphate 30 Gemcitabine 30 Oxaliplatin 26 Leucovorin 24 Immunotherapy, Adoptive 24 Azacitidine 22 Radiation 21 130-nm albumin-bound paclitaxel 21 Ipilimumab 20 Drug Therapy 20 tislelizumab 19 atezolizumab 19 Temozolomide 19 Cytarabine 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05782361 2025-08-20

POTENT

Institute of Cancer Research, United Kingdom

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡